#liver cancer

Checkpoint Immunotherapy Looks Promising for Operable Liver Cancer

Tenofovir was associated with a lower risk of hepatocellular carcinoma, but this might be related to other factors as well.

Study finds that having more diverse gut bacteria was associated with better response to immunotherapy.

Researchers followed nearly 10,000 people with hepatitis C, some of whom were treated with direct-acting antivirals.

The VA has cured HCV in nearly 100,000 veterans, which will dramatically reduce the development of advanced liver disease and liver cancer.

Being diagnosed with liver cancer at a later stage of the disease was associated with a lower three-year survival rate.

A European study of nearly 19,000 people with HIV also found that curing hep C was not associated with heart disease or non-AIDS cancer.

A third of patients taking neoadjuvant Opdivo for inoperable advanced liver cancer had complete responses in an early analysis.

Cabometyx is the third liver cancer drug approved in the past six months.

People with HIV who have higher viral load and worse immune function appear to be at higher risk for hepatocellular carcinoma.

A study found that people who had the largest increase in whole grain lowered their liver cancer risk by nearly 40 percent.

Scientists have firmly established an association between direct-acting antiviral treatment and a lower risk of liver cancer and death.

Researchers compared liver-related death rates among Mexicans, Puerto Ricans and Cubans.

This good news indicates that direct-acting antiviral (DAA) treatment is safe for those who have treated their liver cancer.